IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
about
Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axisSerum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 DiabetesIL-33 induces nuocytes and modulates liver injury in viral hepatitis.The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Interleukin 33: a switch-hitting cytokine.Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunityIL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells.Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cellsT-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses.The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.Interleukin-33 in Tissue Homeostasis, Injury, and InflammationMolecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge modelFull-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashionPresensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness.IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation.Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic GlycolysisControlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunityAn antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.Anti-viral CD8 T cells and the cytokines that they loveCytokine-induced killer cells promote antitumor immunityImplications for Interleukin-33 in solid organ transplantationPeri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33.Role of the IL-33-ST2 axis in sepsis.Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia.IL-33/ST2 axis in inflammation and immunopathology.The evolutionary role of the IL-33/ST2 system in host immune defence.Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies.Cytokine networking of innate immunity cells: a potential target of therapy.Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective.Advances in the diagnosis and therapeutic management of atopic dermatitis.Actual position of interleukin(IL)-33 in atherosclerosis and heart failure: Great Expectations or En attendant Godot?New dog and new tricks: evolving roles for IL-33 in type 2 immunity.Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth.Quantitative phosphoproteomic analysis of IL-33-mediated signalingAlarmin' Immunologists: IL-33 as a Putative Target for Modulating T Cell-Dependent ResponsesInterleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
P2860
Q28397819-59EA0887-EE96-48D1-BF95-FC6CEC4B3D24Q28552483-10DE4A3E-CB0B-4A9A-83EC-BBC2CB0EEAB4Q28588039-CC16526D-C219-40C5-9FE3-C104DE40DDD7Q33593742-9407AED2-DEC8-4D42-B520-263ECBF9679EQ33987547-C1FA9A21-860E-4617-A86E-E50560C0354AQ34033407-0573CCF3-7540-4E5A-839E-3BC53D5B8833Q34289318-84B015D7-77D5-4512-806E-5F0EFD06B465Q34749359-D61BE106-8AE6-4DCE-803D-36C4E6AB84CBQ35279922-086B77B0-708A-41A2-998D-1839F07F26CDQ35607302-5EFE9A0D-F7D7-4441-89F6-7E48B45122D4Q35754479-58300332-F228-4EFB-81ED-912B8FD54A14Q35988587-61F55001-7833-401B-A67F-DC337D44FDFAQ36054682-A389F55C-57CE-4BE6-BA88-27AE96E76512Q36068765-D99B84A1-55A7-4603-ADCE-C4FF478A8BD0Q36070562-5B6A9CFD-ED98-4555-BB1F-4C728A21E1DFQ36130498-949CFE98-CBE9-4774-9492-2FEE414934EFQ36387235-9409DFD7-CB5C-4532-A664-DBFFD82D48CDQ36440299-7F325A8F-6A73-493C-8473-20ABD3C49CCFQ36473012-FD5F91F2-9451-43B8-8CB3-38D54035C0DAQ36517280-E2B7B05F-5819-44C6-A79E-B752C798635CQ36634580-9D314F84-72BB-400A-A888-5FDD2DD76F53Q36741617-21AF42C8-D41C-49C7-BA96-033ECC628B02Q36807908-C42352DD-A977-4D12-8862-ABE5549D415FQ37117633-8F5094FF-80FB-4E26-A071-CFD56069801BQ37251140-9FD47210-BD30-4F75-8529-2F1A01DA4F77Q37620811-336E690B-6DD7-4D72-880B-E5EEF0FADB36Q37641560-FF6538FD-041B-41B3-BA89-17CEDB2BEC05Q37990785-A3C7A4D5-5872-497E-B671-7938FDF2E43CQ38071241-4E93A636-F2E6-4481-A8F2-F5FFAD749AA0Q38105069-E69D3F83-F6D0-4664-8867-E0FA6B8099BAQ38180799-D7A3F384-B20D-4C0B-8C47-4D30F07DF81EQ38189119-C2329A78-3205-46ED-B234-0C8F67C57509Q38211352-47DAE0AB-762E-4089-959A-A2F587C61C67Q38287064-57DD2B74-3586-496B-A688-FBFA153A261CQ38388349-8576C947-2EA9-424E-98EF-06F41E3B301AQ38417709-92031BDA-7622-484A-9F64-36E142131BB6Q38421390-A6394855-0D3F-4EF3-8F2E-520ECD5BC880Q38530106-A7B90BFB-DFC9-424D-B447-C00917406434Q38783993-C6265393-52EF-45E8-8CA0-6A436D5E6712Q38810636-70317546-6DF7-4F4E-9A47-C9C6E5E171F7
P2860
IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
IL-33 synergizes with TCR and ...... ector function of CD8+ T cells
@en
type
label
IL-33 synergizes with TCR and ...... ector function of CD8+ T cells
@en
prefLabel
IL-33 synergizes with TCR and ...... ector function of CD8+ T cells
@en
P2093
P2860
P356
P1476
IL-33 synergizes with TCR and ...... ector function of CD8+ T cells
@en
P2093
Binfeng Lu
Elizabeth Chen
Olivera J Finn
Qianting Yang
Xinchun Chen
Xueguang Zhang
P2860
P304
P356
10.1002/EJI.201141629
P407
P577
2011-10-13T00:00:00Z